CIK 0001937653 · Non-accelerated filer<br>Smaller reporting company
Zymeworks Inc.
Sign in to watch- Ticker
- ZYME
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 883099146
- Phone
- 302-274-8744
- Business address
- 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
- Former names
- Zymeworks Delaware Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $357,557
- in 1 filing
Net −$357,557. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | Moore Paul Andrew Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2023-01-05 | Moore Paul Andrew Chief Scientific Officer | Grant or award · Restricted Stock Unit | +51,500 | 51,500 | ||
| 2022-12-22 | Galbraith Kenneth Chair & CEO | Grant or award · Restricted Stock Unit | +100,000 | 100,000 | ||
| 2022-12-21 | Sacks Natalie Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-21 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-21 | Cox Troy Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-21 | Zoth Lota S. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-21 | Neu Kelvin Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-21 | Hillan Kenneth J. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-21 | RENTON HOLLINGS Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-12 | Astle Christopher SVP & Chief Financial Officer | Option exercise | +1,550 | 2,220 | ||
| 2022-12-12 | Astle Christopher SVP & Chief Financial Officer | Sale | −887 | $6.01 | $5K | 1,333 |
| 2022-12-12 | Astle Christopher SVP & Chief Financial Officer | Option exercise · Restricted Stock Unit | −1,550 | 1,550 | ||
| 2022-12-12 | Astle Christopher SVP & Chief Financial Officer | Option exercise | +1,550 | 2,220 | ||
| 2022-12-12 | Astle Christopher SVP & Chief Financial Officer | Sale | −887 | $6.01 | $5K | 1,333 |
| 2022-12-12 | Astle Christopher SVP & Chief Financial Officer | Option exercise · Restricted Stock Unit | −1,550 | 1,550 | ||
| 2022-11-10 | Josephson Neil Chief Medical Officer | Option exercise | +5,885 | 16,924 | ||
| 2022-11-10 | Josephson Neil Chief Medical Officer | Sale | −2,475 | $8.10 | $20K | 14,449 |
| 2022-11-10 | Josephson Neil Chief Medical Officer | Option exercise · Restricted Stock Unit | −5,885 | 11,772 | ||
| 2022-11-10 | Josephson Neil Chief Medical Officer | Option exercise | +5,885 | 16,924 |
Page 11 of 12 · 224 trades